206 related articles for article (PubMed ID: 19567247)
1. WHO Guide for standardisation of economic evaluations of immunization programmes.
Walker DG; Hutubessy R; Beutels P
Vaccine; 2010 Mar; 28(11):2356-9. PubMed ID: 19567247
[TBL] [Abstract][Full Text] [Related]
2. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination: cost-effectiveness ratio].
Swennen B
Rev Med Brux; 2009 Sep; 30(4):451-7. PubMed ID: 19899394
[TBL] [Abstract][Full Text] [Related]
4. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community.
Poulos C; Bahl R; Whittington D; Bhan MK; Clemens JD; Acosta CJ
J Health Popul Nutr; 2004 Sep; 22(3):311-21. PubMed ID: 15609784
[TBL] [Abstract][Full Text] [Related]
5. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
6. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
7. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.
Colantonio L; Gómez JA; Demarteau N; Standaert B; Pichón-Rivière A; Augustovski F
Vaccine; 2009 Sep; 27(40):5519-29. PubMed ID: 19616499
[TBL] [Abstract][Full Text] [Related]
10. Economic analyses of rubella and rubella vaccines: a global review.
Hinman AR; Irons B; Lewis M; Kandola K
Bull World Health Organ; 2002; 80(4):264-70. PubMed ID: 12075361
[TBL] [Abstract][Full Text] [Related]
11. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination--value for money?].
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767
[TBL] [Abstract][Full Text] [Related]
13. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for the Expanded Programme on Immunization.
Cutts FT; Waldman RJ; Zoffman HM
Bull World Health Organ; 1993; 71(5):633-9. PubMed ID: 8261567
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
16. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
[TBL] [Abstract][Full Text] [Related]
17. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
18. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
Phillips KA; Hotlgrave DR
Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
[TBL] [Abstract][Full Text] [Related]
19. Discounting in health care decision-making: time for a change?
Sheldon TA
J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of immunization strategies.
Ess SM; Szucs TD
Clin Infect Dis; 2002 Aug; 35(3):294-7. PubMed ID: 12115095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
